•  
  •  
  •  
  •  

2026-07-31 00:47:04

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • SEDEMAC Mechatronics Reports Q1 FY27 Results: Net Profit Surges 95.1% YoY to ₹33.31 Crore
  • Unified Data Tech Solutions Ltd - Q1FY27 Business Update
  • IRIS RegTech Solutions Bagging Contract Extension for South Africa's CODI Deposit Insurance Project
  • Glenmark Pharmaceuticals Inc., USA launches Sugammadex Injection, 200 mg/2 mL (100 mg/mL) and 500 mg/5 mL (100 mg/mL) Single-Dose Vials
  • RPG Life Sciences Reports Q1 FY27 Results: Consolidated Net Profit Up 17% YoY to ₹30.76 Crore

Keywords Selected:  USALaunch

Stock Report

  • Glenmark Pharmaceuticals Inc., USA launches Olanzapine for Injection, 10 mg/vial, Single-Dose Vial
  • Lupin announces the approval and launch of Brivaracetam Oral Solution in the United States
  • Glenmark Pharmaceuticals Inc., USA launches Epinephrine Injection USP, 30 mg/30 mL (1 mg/mL) Multiple-Dose Vial
  • Glenmark Pharmaceuticals Inc., USA to launch 8.4% Sodium Bicarbonate Injection USP, 50 mEq/50 mL (1 mEq/mL) Single-Dose Vial
  • Lupin launches Loteprednol Etabonate Ophthalmic Suspension, 0.5% in the United States
  • Glenmark Pharmaceuticals Inc., USA acquires and launches Acetylcysteine Injection, 6 gm/30 mL (200 mg/mL) Single-Dose Vials
  • Glenmark Pharmaceuticals Inc., USA launches Phytonadione Injectable Emulsion USP, 10 mg/mL Single Dose Ampules

Latest Post

  • SEDEMAC Mechatronics Reports Q1 FY27 Results: Net Profit Surges 95.1% YoY to ₹33.31 Crore
  • Unified Data Tech Solutions Ltd - Q1FY27 Business Update
  • IRIS RegTech Solutions Bagging Contract Extension for South Africa's CODI Deposit Insurance Project
  • Glenmark Pharmaceuticals Inc., USA launches Sugammadex Injection, 200 mg/2 mL (100 mg/mL) and 500 mg/5 mL (100 mg/mL) Single-Dose Vials
  • RPG Life Sciences Reports Q1 FY27 Results: Consolidated Net Profit Up 17% YoY to ₹30.76 Crore


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2025